ABBV · earnings call history
AbbVie Q1 FY26 — Skyrizi/Rinvoq momentum drives beat and raised FY EPS guide
Read the briefAbbVie Q4 FY25 — Strong Immunology and Neuroscience Drive Record Sales and Exceed Guidance
Read the briefAbbVie Q3 FY25 — Strong Growth Platform Drives Raised FY25 Outlook
Read the briefAbbVie Q1 FY25 — Strong Ex-Humira Growth and Raised FY25 EPS Guidance
Read the briefAbbVie Q4 FY24 — Ex-Humira Platform Drives Strong Growth and Raised Outlook
Read the briefBrowse all US companies on the earnings-call register.